Table 4.
Infants (12 weeks–11 months) | Toddlers (12–35 months) | Children (3–9 years) | Adolescents (10–17 years) | Adults (18–64 years) | The elderly (≥ 65 years) | |
---|---|---|---|---|---|---|
Maximum level exposure assessment scenario | ||||||
|
3.5–42.8 11.5–109.6 |
8.0–131.1 20.9–160.4 |
16.2–97.3 34.7–173.9 |
7.7–60.5 19.2–106.2 |
21.6–38.4 46.0–74.8 |
21.3–33.6 36.5–65.5 |
Refined estimated exposure assessment scenario | ||||||
Brand‐loyal scenario | ||||||
|
3.1–41.5 10.3–106.9 |
6.7–110.2 16.8–142.3 |
12.6–81.6 27.8–162.3 |
6.0–47.8 16.3–94.0 |
19.7–32.7 39.7–70.3 |
18.3–31.4 33.6–63.7 |
Non‐brand‐loyal scenario | ||||||
|
1.4–14.5 5.4–38.2 |
4.3–54.7 12.6–58.2 |
8.6–40.6 18.2–69.9 |
4.0–22.7 10.2–39.9 |
6.6–14.4 13.9–27.8 |
6.3–11.8 11.9–22.6 |